ARCHIVES

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

This article is from The Cancer Letter archive.

Vol. 10 No. 16 | April 20, 1984

Download PDF Visit The Full Archive

Related Articles

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

New Yorkers Agree Cancer Program Needs More Money

June 7, 1985

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

NIH Defines Misconduct

December 9, 1994